|
| 37169337 | Pediatric Tumors and Developmental Anomalies: A French Nationwide Cohort Study. | J Pediatr | 2023 |
| 36250317 | Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France. | Int J Cancer | 2023 |
| 36307659 | All pineal tumors expressing germ cell tumor markers are not necessarily germ cell tumors: histopathological and molecular study of a midline primary intracranial sarcoma DICER1-mutant. | Virchows Arch | 2023 |
| 36400694 | Challenges in glioblastoma research: focus on the tumor microenvironment. | | 2023 |
| 37723198 | A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors. | Commun Biol | 2023 |
| 36835950 | Retrospective National "Real Life" Experience of the SFCE with the Metronomic MEMMAT and MEMMAT-like Protocol. | J Clin Med | 2023 |
| 36831610 | Molecular Heterogeneity in BRAF-Mutant Gliomas: Diagnostic, Prognostic, and Therapeutic Implications. | | 2023 |
| 36900302 | p16 Immunohistochemical Expression as a Surrogate Assessment of CDKN2A Alteration in Gliomas Leading to Prognostic Significances. | | 2023 |
| 37399010 | Measuring Safety and Outcomes for the Use of Compassionate and Off-Label Therapies for Children, Adolescents, and Young Adults With Cancer in the SACHA-France Study. | | 2023 |
| 36868501 | French cohort of children and adolescents with neurofibromatosis type 1 and symptomatic inoperable plexiform neurofibromas: CASSIOPEA study. | | 2023 |
| 36997420 | Challenges in glioblastoma research: focus on the tumor microenvironment: (Trends in Cancer, 9:1 p:9-27, 2023). | Trends Cancer | 2023 |
| 37046681 | Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX). | | 2023 |
| 37298093 | Glioblastoma Metabolism: Insights and Therapeutic Strategies. | | 2023 |
| 35053532 | Temozolomide-Acquired Resistance Is Associated with Modulation of the Integrin Repertoire in Glioblastoma, Impact of α5β1 Integrin. | Cancers (Basel) | 2022 |
| 35751658 | Impact of pharmacogenetics on variability in exposure to oral vinorelbine among pediatric patients: a model-based population pharmacokinetic analysis. | Cancer Chemotherapy and Pharmacology | 2022 |
| 35373885 | Retrospective and integrative analyses of molecular characteristics and their specific imaging parameters in pediatric grade 1 gliomas. | Pediatric Blood and Cancer | 2022 |
| 36057996 | Engineering Novel 3D Models to Recreate High-Grade Osteosarcoma and its Immune and Extracellular Matrix Microenvironment. | Advanced healthcare materials | 2022 |
| 34718043 | Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohort. | J Allergy Clin Immunol | 2022 |
| 34709655 | Pharmacokinetics of oral vinorelbine in French children with recurrent or progressive primary low-grade glioma. | British Journal of Clinical Pharmacology | 2022 |
| 35078815 | Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at Diagnosis. | Cancer Res | 2022 |
| 35326631 | Together Intra-Tumor Hypoxia and Macrophagic Immunity Are Driven Worst Outcome in Pediatric High-Grade Osteosarcomas. | Cancers (Basel) | 2022 |
| 29776650 | Signaling pathway deregulation and molecular alterations across pediatric medulloblastomas. | Neurochirurgie | 2021 |
| 33808416 | Sirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology. | Pharmaceutics | 2021 |
| 34169282 | Droplet digital PCR-based detection of circulating tumor DNA from pediatric high grade and diffuse midline glioma patients. | Neurooncol Adv | 2021 |
| 34067180 | A DNA Repair and Cell Cycle Gene Expression Signature in Pediatric High-Grade Gliomas: Prognostic and Therapeutic Value. | Cancers | 2021 |
| 33999421 | SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type. | J Pathol | 2021 |
| 33498676 | Characterization of Macrophages and Osteoclasts in the Osteosarcoma Tumor Microenvironment at Diagnosis: New Perspective for Osteosarcoma Treatment? | Cancers (Basel) | 2021 |
| 33377141 | Prognostic relevance of clinical and molecular risk factors in children with high-risk medulloblastoma treated in the phase II trial PNET HR+5. | Neuro Oncol | 2021 |
| 33140906 | Biological Relevance of RGD-Integrin Subtype-Specific Ligands in Cancer. | ChemBioChem | 2021 |
| 33340509 | Cerebellar swelling after surgery for medulloblastoma with leptomeningeal dissemination in children. A case based-update. | Neurochirurgie | 2021 |
| 34866620 | Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions. | Journal of Visualized Experiments | 2021 |
| 34562750 | Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)<sup>â¿¿</sup>. | ESMO Open | 2021 |
| 34830833 | Impact of Chromatin Dynamics and DNA Repair on Genomic Stability and Treatment Resistance in Pediatric High-Grade Gliomas. | Cancers | 2021 |
| 34416158 | Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study. | Lancet Oncol | 2021 |
| 32700439 | Long-term follow-up of children with risk organ-negative Langerhans cell histiocytosis after 2-chlorodeoxyadenosine treatment. | British Journal of Haematology | 2020 |
| 32432211 | Pheochromocytoma and Paraganglioma in Children and Adolescents: Experience of the French Society of Pediatric Oncology (SFCE). | J Endocr Soc | 2020 |
| 32326644 | Hypoxia Inducible Factors' Signaling in Pediatric High-Grade Gliomas: Role, Modelization and Innovative Targeted Approaches. | Cancers | 2020 |
| 32078813 | Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial. | Lancet Oncol | 2020 |
| 31571386 | Spinal cord atypical teratoid/rhabdoid tumors in children: Clinical, genetic, and outcome characteristics in a representative European cohort. | Pediatr Blood Cancer | 2020 |
| 32878021 | Focus on Hypoxia-Related Pathways in Pediatric Osteosarcomas and Their Druggability. | Cells | 2020 |
| 33092063 | SFCE-RAPIRI Phase I Study of Rapamycin Plus Irinotecan: A New Way to Target Intra-Tumor Hypoxia in Pediatric Refractory Cancers. | Cancers | 2020 |
| 31358461 | Denosumab for treating aneurysmal bone cysts in children. | Orthop Traumatol Surg Res | 2019 |
| 31779235 | Hypoxic Environment and Paired Hierarchical 3D and 2D Models of Pediatric -Mutated Gliomas Recreate the Patient Tumor Complexity. | Cancers | 2019 |
| 31037432 | An integrated genomic and metabolomic approach for defining survival time in adult oligodendrogliomas patients. | Metabolomics | 2019 |
| 31522324 | Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand? | J Neurooncol | 2019 |
| 31401750 | A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency. | Journal of Clinical Immunology | 2019 |
| 29190507 | Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study. | Eur J Cancer | 2018 |
| 30112115 | Association between genetic polymorphisms and platinum-induced ototoxicity in children. | Oncotarget | 2018 |
| 29967352 | Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells. | Nat Med | 2018 |
| 30319400 | Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial. | Frontiers in Pharmacology | 2018 |